These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22373701)

  • 1. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
    De Broe ME
    Kidney Int; 2012 Mar; 81(6):513-5. PubMed ID: 22373701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.
    Jelaković B; Karanović S; Vuković-Lela I; Miller F; Edwards KL; Nikolić J; Tomić K; Slade N; Brdar B; Turesky RJ; Stipančić Ž; Dittrich D; Grollman AP; Dickman KG
    Kidney Int; 2012 Mar; 81(6):559-67. PubMed ID: 22071594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balkan endemic nephropathy: an update on its aetiology.
    Stiborová M; Arlt VM; Schmeiser HH
    Arch Toxicol; 2016 Nov; 90(11):2595-2615. PubMed ID: 27538407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
    Cosyns JP
    Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.
    Arlt VM; Pfohl-Leszkowicz A; Cosyns J; Schmeiser HH
    Mutat Res; 2001 Jul; 494(1-2):143-50. PubMed ID: 11423353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.
    Slade N; Moll UM; Brdar B; Zorić A; Jelaković B
    Mutat Res; 2009 Apr; 663(1-2):1-6. PubMed ID: 19428366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
    Hollstein M; Moriya M; Grollman AP; Olivier M
    Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
    Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
    Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
    Grollman AP
    Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
    Grollman AP; Shibutani S; Moriya M; Miller F; Wu L; Moll U; Suzuki N; Fernandes A; Rosenquist T; Medverec Z; Jakovina K; Brdar B; Slade N; Turesky RJ; Goodenough AK; Rieger R; Vukelić M; Jelaković B
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12129-34. PubMed ID: 17620607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.
    Jelaković B; Dika Ž; Arlt VM; Stiborova M; Pavlović NM; Nikolić J; Colet JM; Vanherweghem JL; Nortier JL
    Semin Nephrol; 2019 May; 39(3):284-296. PubMed ID: 31054628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
    Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
    Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.
    Arlt VM; Stiborová M; vom Brocke J; Simões ML; Lord GM; Nortier JL; Hollstein M; Phillips DH; Schmeiser HH
    Carcinogenesis; 2007 Nov; 28(11):2253-61. PubMed ID: 17434925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours.
    Pfohl-Leszkowicz A
    Arh Hig Rada Toksikol; 2009 Dec; 60(4):465-83. PubMed ID: 20061248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.
    Gökmen MR; Cosyns JP; Arlt VM; Stiborová M; Phillips DH; Schmeiser HH; Simmonds MS; Cook HT; Vanherweghem JL; Nortier JL; Lord GM
    Ann Intern Med; 2013 Mar; 158(6):469-77. PubMed ID: 23552405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urothelial carcinoma associated with Balkan endemic nephropathy. A worldwide disease.
    Stefanovic V; Polenakovic M; Toncheva D
    Pathol Biol (Paris); 2011 Oct; 59(5):286-91. PubMed ID: 19896305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia.
    Grollman AP; Jelaković B
    J Am Soc Nephrol; 2007 Nov; 18(11):2817-23. PubMed ID: 17942951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic remedies based on Aristolochia clematitis in the main foci of Balkan endemic nephropathy in Romania.
    Gluhovschi G; Margineanu F; Kaycsa A; Velciov S; Gluhovschi C; Bob F; Petrica L; Bozdog G; Dumitru S; Olosz E; Modalca M
    Nephron Clin Pract; 2010; 116(1):c36-46. PubMed ID: 20484934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania.
    Schmeiser HH; Kucab JE; Arlt VM; Phillips DH; Hollstein M; Gluhovschi G; Gluhovschi C; Modilca M; Daminescu L; Petrica L; Velciov S
    Environ Mol Mutagen; 2012 Oct; 53(8):636-41. PubMed ID: 22987305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?
    Arlt VM; Ferluga D; Stiborova M; Pfohl-Leszkowicz A; Vukelic M; Ceovic S; Schmeiser HH; Cosyns JP
    Int J Cancer; 2002 Oct; 101(5):500-2. PubMed ID: 12216081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.